Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Optimizing Acute Care Rehabilitation for Critically Ill Adults

13. November 2026 aktualisiert von: University of Colorado, Denver

The goal of this clinical trial is to determine the optimal frequency, duration, and timing of physical therapy (PT) and occupational therapy (OT) rehabilitation to improve physical and cognitive function in critically ill adults receiving mechanical ventilation in the intensive care unit (ICU).

The main questions it aims to answer are:

  1. What combination of rehabilitation session frequency, session duration, and timing of OT initiation produces the greatest improvements in physical function and activities of daily living at hospital discharge and 3 months?
  2. Which patient characteristics, including age and comorbidities, are associated with greater benefits from different rehabilitation approaches?

Researchers will compare eight combinations of rehabilitation strategies, varying three components:

Session frequency: 4 versus 7 days per week. Session duration: 20 versus 40 minutes per session. Timing of OT initiation: Early initiation (within 24 hours of randomization) versus delayed initiation (at ICU discharge or 7 days after randomization, whichever occurs later).

Participants will:

  • Be randomly assigned to one of eight rehabilitation combinations.
  • Receive individualized, progressive PT focused on strength, balance, mobility, and endurance, beginning within 24 hours of randomization.
  • Receive individualized OT focused on daily activities, including grooming, bathing, dressing, and feeding, beginning according to their assigned group.
  • Participate in rehabilitation sessions until hospital discharge, 21 days after randomization, or successful completion of predefined rehabilitation milestones, whichever occurs first.
  • Undergo assessments of physical function, daily activities, and cognitive function during hospitalization and at hospital discharge.
  • Complete a follow-up assessment 3 months after hospital discharge to evaluate physical and cognitive function, quality of life, mental health, and recovery.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Survivors of critical illness frequently experience persistent physical and cognitive impairments that limit functional independence and quality of life. Intensive care unit (ICU)-acquired weakness is a major contributor to poor recovery, and prolonged bed rest can further accelerate muscle weakness and functional decline. Although ICU-initiated rehabilitation delivered by physical therapists (PTs) and occupational therapists (OTs) has demonstrated benefits, considerable uncertainty remains regarding the optimal frequency and duration of rehabilitation sessions and the appropriate timing of OT initiation.

This multicenter randomized clinical trial will use the Multiphase Optimization Strategy (MOST) framework to systematically evaluate and optimize the delivery of ICU-initiated rehabilitation. The study will employ a 2×2×2 factorial design to assess the individual and combined effects of three rehabilitation components: session frequency, session duration, and timing of OT initiation. The trial will enroll 360 critically ill adults receiving mechanical ventilation across participating academic medical centers.

The rehabilitation intervention consists of established PT and OT approaches delivered through a standardized, individualized, and progressive framework. PT will target strength, balance, mobility, and endurance, while OT will focus on activities of daily living, including grooming, bathing, dressing, and feeding. Rehabilitation activities will be tailored to each participant's functional capabilities and clinical condition, with progression guided by predefined performance milestones. Both interventions are also designed to engage cognitive processes through task repetition, sequencing, cueing, and problem-solving.

The study will evaluate the effects of different rehabilitation combinations on physical function, performance of daily activities, and cognition during hospitalization and at 3-month follow-up. Additional assessments will characterize recovery across domains including muscle strength, mobility, exercise capacity, cognitive function, health-related quality of life, mental health, and healthcare utilization.

In addition to determining the most effective combination of rehabilitation components, the study will examine whether patient-level characteristics, particularly age and comorbidity burden, are associated with differences in treatment response. Using a hybrid efficacy-implementation approach, quantitative and qualitative findings will inform optimization based on effectiveness, affordability, scalability, and efficiency.

The overall objective is to identify an evidence-based, resource-conscious rehabilitation strategy that maximizes functional recovery following critical illness and is suitable for evaluation in a subsequent clinical trial and eventual implementation in routine clinical practice.

Studientyp

Interventionell

Einschreibung (Geschätzt)

360

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

  • Name: Rafaela Mantelli, MD
  • Telefonnummer: 303-724-0961

Studienorte

    • Colorado
      • Aurora, Colorado, Vereinigte Staaten, 80045
        • University of Colorado, Anshcutz Medical Campus
        • Hauptermittler:
          • Marc Moss, MD
        • Kontakt:
    • Illinois
      • Chicago, Illinois, Vereinigte Staaten, 60637
        • University of Chicago Hospital
        • Kontakt:
        • Hauptermittler:
          • Bhakti Patel, MD
    • Maryland
      • Baltimore, Maryland, Vereinigte Staaten, 21287
        • Johns Hopkins
        • Kontakt:
        • Hauptermittler:
          • Dale M Needham, MD
    • North Carolina
      • Durham, North Carolina, Vereinigte Staaten, 27710
        • Duke University Medical Center
        • Kontakt:

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • ICU patients age >18 years.
  • Mechanically ventilated for <48 hours.
  • Expected to require mechanical ventilation for >24 hours at the time of randomization.

Exclusion Criteria:

  • Pre-existing functional impairment defined as a Barthel score <70.
  • Pre-existing cognitive impairment using an IQCODE cutoff of 3.42.
  • Acute brain pathology (e.g., traumatic brain injury, stroke) without exclusion for ICU-delirium.
  • Proven or suspected spinal cord injury or neuromuscular disease that will result in permanent or prolonged weakness (without exclusion for ICU-acquired weakness) at time of eligibility.
  • Has "bedrest" orders and/or non-weight bearing orders for lower limbs at time of eligibility.
  • Life expectancy <180 days due to chronic medical condition (per judgement of clinical team).
  • Limitation in use of life support (excluding a sole "No CPR/DNR" order) at time of eligibility.
  • Death deemed inevitable due to severity of critical illness at time of eligibility (per clinical team).
  • Unable to understand/communicate in English.
  • Not the first ICU admission during the index hospital admission.
  • More than 72 hours since meeting all eligibility (to allow potential for early intervention).

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Fakultätszuweisung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Low Frequency / Short Duration / Delayed Occupational Therapy (OT)

Participants will receive physical therapy (PT) and occupational therapy (OT) rehabilitation 4 days per week, with 20-minute sessions. PT will begin within 24 hours of randomization. OT will begin at ICU discharge or 7 days after randomization, whichever occurs later.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: Low Frequency / Short Duration / Early Occupational Therapy (OT)

Participants will receive physical therapy (PT) and occupational therapy (OT) rehabilitation 4 days per week, with 20-minute sessions. Both PT and OT will begin within 24 hours of randomization.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: Low Frequency / Long Duration / Delayed Occupational Therapy (OT)

Participants will receive physical therapy (PT) and occupational therapy (OT) rehabilitation 4 days per week, with 40-minute sessions. PT will begin within 24 hours of randomization. OT will begin at ICU discharge or 7 days after randomization, whichever occurs later.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: Low Frequency / Long Duration / Early Occupational Therapy (OT)

Participants will receive physical therapy (PT) and occupational therapy (OT) rehabilitation 4 days per week, with 40-minute sessions. Both PT and OT will begin within 24 hours of randomization.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: High Frequency / Short Duration / Delayed Occupational Therapy (OT)

Participants will receive PT and OT rehabilitation 7 days per week, with 20-minute sessions. PT will begin within 24 hours of randomization. OT will begin at ICU discharge or 7 days after randomization, whichever occurs later.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: High Frequency / Short Duration / Early Occupational Therapy (OT)

Participants will receive PT and OT rehabilitation 7 days per week, with 20-minute sessions. Both PT and OT will begin within 24 hours of randomization.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: High Frequency / Long Duration / Delayed Occupational Therapy (OT)

Participants will receive PT and OT rehabilitation 7 days per week, with 40-minute sessions. PT will begin within 24 hours of randomization. OT will begin at ICU discharge or 7 days after randomization, whichever occurs later.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: High Frequency / Long Duration / Early Occupational Therapy (OT)

Participants will receive PT and OT rehabilitation 7 days per week, with 40-minute sessions. Both PT and OT will begin within 24 hours of randomization.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Short Physical Performance Battery (SPPB) Score
Zeitfenster: Day of hospital discharge, up to 1 year.

Lower extremity physical function will be assessed using the Short Physical Performance Battery (SPPB), which includes standing balance, repeated chair stands, and gait speed. Total scores range from 0 to 12, with higher scores indicating better physical performance.

Day of hospital discharge, up to 1 year.
Activity Measure for Post-Acute Care (AM-PAC) Daily Activity Score
Zeitfenster: Day of hospital discharge, up to 1 year.

Ability to perform activities of daily living will be assessed using the AM-PAC Daily Activity Inpatient Short Form. The instrument measures functional performance in daily activities, including upper extremity function. Scores are reported using a standardized scoring system, with a range from 6 to 24, with higher scores indicating better functional performance.

Day of hospital discharge, up to 1 year.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Medical Research Council (MRC) Sum-Score
Zeitfenster: Day of hospital discharge, up to 1 year.

Upper and lower extremity muscle strength will be evaluated by standardized manual muscle testing using the Medical Research Council (MRC) sum-scale. Sacel ranges from 0 to 60, with higher scores indicating better global muscle strength.

Day of hospital discharge, up to 1 year.
Handgrip Strength
Zeitfenster: through study completion, an average of 1 year

Muscle strength will be assessed using grip dynamometry of the dominant hand.

through study completion, an average of 1 year
Nine-Hole Peg Test
Zeitfenster: through study completion, an average of 1 year

Upper extremity motor dexterity will be evaluated using the Nine-Hole Peg Test, which assesses performance of a standardized manual dexterity task by timing how long it takes the participant to complete the task.

through study completion, an average of 1 year
Johns Hopkins Highest Level of Mobility (JH-HLM) Score
Zeitfenster: Starting at Baseline (Day 0), daily assessments, through study completion, an average of 1 year

Patient mobility will be assessed using the one-item Johns Hopkins Highest Level of Mobility scale, which evaluates the highest level of mobility achieved. Scale ranges from 0 to 8, with higher scores indicating better mobility.

Starting at Baseline (Day 0), daily assessments, through study completion, an average of 1 year
Functional Status Score for the ICU (FSS-ICU)
Zeitfenster: Starting at Baseline (Day 0), daily assessments, through study completion, an average of 1 year

Functional mobility will be assessed using the FSS-ICU, which evaluates five tasks: rolling, supine-to-sit transfer, sitting at the edge of the bed, sit-to-stand transfer, and walking. The scale ranges from 0 to 35 points, with higher scores indicating better physical functioning and greater independence.

Starting at Baseline (Day 0), daily assessments, through study completion, an average of 1 year
Activity Measure for Post-Acute Care (AM-PAC) Short Forms
Zeitfenster: Daily assessments, through study completion, an average of 1 year

Functional mobility will be assessed using the Activity Measure for Post-Acute Care (AM-PAC) Mobility Short Form, which ranges from 6 to 24, with higher scores indicating better functional performance. Applied cognitive functioning will be assessed using the Activity Measure for Post-Acute Care (AM-PAC) Applied Cognition Short Form, which ranges from 0 to 39, with higher scores indicating better cognitive functional performance.

Daily assessments, through study completion, an average of 1 year
Six-Minute Walk Test (6MWT) Distance
Zeitfenster: On day of hospital discharge, up to 1 year.

Functional exercise capacity will be assessed using the Six-Minute Walk Test, which measures the distance walked during a six-minute period. The greater the distance the better functional exercise capacity, higher aerobic endurance, and improved overall mobility or cardiopulmonary function.

On day of hospital discharge, up to 1 year.

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Montreal Cognitive Assessment (MoCA) Score
Zeitfenster: On day of hospital discharge, and up to 1 year.

Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a standardized screening instrument for cognitive impairment. The assessment ranges from 0 to 30, where higher scores indicate better cognitive function and a lower level of impairment.

On day of hospital discharge, and up to 1 year.
Richmond Agitation-Sedation Scale (RASS) Score
Zeitfenster: Daily during hospitalization, from Day 0 until hospital discharge, up to 1 year.

Sedation and agitation status will be evaluated using the Richmond Agitation-Sedation Scale (RASS). Ranges from -5 to +4, with higher scores indicating increasing levels of agitation, hyperactivity, or combativeness.

Daily during hospitalization, from Day 0 until hospital discharge, up to 1 year.
Confusion Assessment Method for the ICU (CAM-ICU)
Zeitfenster: Daily during hospitalization, from Day 0 until hospital discharge, up to 1 year.

Delirium status in the ICU will be assessed using the Confusion Assessment Method for the ICU (CAM-ICU). The scale ranges from 0 to 7, with higher scores indicating greater severity of delirium.

Daily during hospitalization, from Day 0 until hospital discharge, up to 1 year.
Survival Status
Zeitfenster: through study completion, an average of 1 year

Survival status will be determined through medical record review during hospitalization and telephone follow-up at 3 months.

through study completion, an average of 1 year
Duration of Mechanical Ventilation
Zeitfenster: Daily during hospitalization, on the day of hospital discharge, up to 1 year.

Total duration of mechanical ventilation during the index hospitalization will be determined through medical record review.

Daily during hospitalization, on the day of hospital discharge, up to 1 year.
Intensive Care Unit (ICU) and Hospital Length of Stay
Zeitfenster: Daily during hospitalization, on the day of hospital discharge, up to 1 year.

Length of stay in the intensive care unit during and hospital length of stay in the index hospitalization will be determined through medical record review.

Daily during hospitalization, on the day of hospital discharge, up to 1 year.
Hospital Discharge Location
Zeitfenster: day of hospital discharge, up to 1 year.

Discharge destination, including home or a rehabilitation facility, will be determined through medical record review.

day of hospital discharge, up to 1 year.
Health-Related Quality of Life (EQ-5D-5L)
Zeitfenster: 3 months after hospital discharge, up to 1 year.

Health-related quality of life will be assessed using the five-level EuroQol five-dimension questionnaire (EQ-5D-5L). Ranges from 0 to 1, with higher scores indicating better health-related quality of life (1 represents full/perfect health; 0 represents death).

3 months after hospital discharge, up to 1 year.
Hospital Anxiety and Depression Scale (HADS) Score
Zeitfenster: 3 months after hospital discharge, up to 1 year.

Symptoms of anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale (HADS). The total score range is from 0 to 42, with higher scors indicating greater severity of anxiety or depressive symptoms.

3 months after hospital discharge, up to 1 year.
Impact of Event Scale-6 (IES-6) Score
Zeitfenster: 3 months after hospital discharge, up to 1 year.

Symptoms of post-traumatic stress will be assessed using the six-item Impact of Event Scale (IES-6). Scores range from 0 to 18, with elevated scores pointing toward a greater probability of clinically relevant posttraumatic stress disorder or significant trauma-related impact.

3 months after hospital discharge, up to 1 year.
Clinical Frailty Scale Score
Zeitfenster: 3 months after hospital discharge, up to 1 year.

Frailty will be assessed using the Clinical Frailty Scale, the scale ranges from 1 to 9, with higher scores indicating a greater degree of functional dependence, vulnerability, and physiological decline

3 months after hospital discharge, up to 1 year.
Modified Medical Research Council Dyspnea (mMRC) Score
Zeitfenster: 3 months after hospital discharge, up to 1 year.

Pulmonary symptoms will be assessed using the one-item Modified Medical Research Council Dyspnea scale. The scale ranges from 0 to 4, with higher scores indicating greater severity of breathlessness and functional disability.

3 months after hospital discharge, up to 1 year.
Self-Reported Recovery Scale
Zeitfenster: 3 months after hospital discharge, up to 1 year.

Self-perceived overall recovery following critical illness will be assessed using the one-item Recovery Scale from an established core outcome set, where the highest number indicates completely recovered.

3 months after hospital discharge, up to 1 year.
Health Care Utilization
Zeitfenster: 3 months after hospital discharge, up to 1 year.

Health care utilization, including admissions to hospitals, skilled nursing facilities, and rehabilitation facilities, will be assessed using a telephone survey supplemented by medical record review.

3 months after hospital discharge, up to 1 year.
Days Alive and Out of Hospital
Zeitfenster: 3 months after hospital discharge, up to 1 year.

Days alive and out of hospital will be calculated using information collected through the Health Care Utilization Survey.

3 months after hospital discharge, up to 1 year.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Mitarbeiter

Ermittler

  • Hauptermittler: Marc Moss, MD, University of Colorado, Department of Pulmonary, Allergy and Critical Care Medicine

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Dezember 2026

Primärer Abschluss (Geschätzt)

1. Juli 2030

Studienabschluss (Geschätzt)

31. August 2031

Studienanmeldedaten

Zuerst eingereicht

29. Oktober 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

13. November 2026

Zuerst gepostet (Tatsächlich)

18. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

13. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 26-0711
  • 1R01AG099962 (US NIH Stipendium/Vertrag)

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .